Bayer Aktiengesellschaft (BAYZF)
OTCMKTS
· Delayed Price · Currency is USD
24.68
+0.20 (0.82%)
Apr 22, 2025, 4:00 PM EDT
Bayer Aktiengesellschaft Revenue
In the year 2024, Bayer Aktiengesellschaft had annual revenue of 46.61B EUR, down -2.16%. Bayer Aktiengesellschaft had revenue of 11.73B in the quarter ending December 31, 2024, a decrease of -1.12%.
Revenue
46.61B EUR
Revenue Growth
-2.16%
P/S Ratio
0.51
Revenue / Employee
514.49K EUR
Employees
90,587
Market Cap
24.69B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 46.61B | -1.03B | -2.16% |
Dec 31, 2023 | 47.64B | -3.10B | -6.11% |
Dec 31, 2022 | 50.74B | 6.66B | 15.10% |
Dec 31, 2021 | 44.08B | 2.68B | 6.48% |
Dec 31, 2020 | 41.40B | -2.15B | -4.93% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SS Innovations International | 20.65M |
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
Glass House Brands | 200.90M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Bayer Aktiengesellschaft News
- 14 hours ago - World Bank adds Bayer, Hyatt and other CEOs to private sector initiative - Reuters
- 1 day ago - ConcertAI Announces Strategic Agreement with Bayer to Accelerate Clinical Development in Precision Oncology - Business Wire
- 1 day ago - ConcertAI Announce Strategic Agreement with Bayer to Accelerate Clinical Development in Precision Oncology - Business Wire
- 2 days ago - CEO do Bayer revela 'acordo de cavalheiros' para liberar Xabi, alvo do Real - UOL
- 6 days ago - Bayer CEO: targeting US state regulation to stem glyphosate costs - Reuters
- 7 days ago - Bayer Unveils $44 Million Investment in Myerstown, PA Manufacturing Facility, Renewing Commitment to U.S. Innovation, Health and Community - Business Wire
- 7 days ago - Bayer to Unveil Latest NUBEQA® (darolutamide) Data and Prostate Cancer Research at American Urological Association (AUA) 2025 Annual Meeting - Business Wire
- 9 days ago - Bayer is said to consider ending production of Roundup amid legal costs - Seeking Alpha